Dr. Berenson is the Medical & Scientific Director as well as the Chief Executive Officer of Oncotherapeutics and the Institute for Myeloma & Bone Cancer Research (IMBCR). He also has his private practice located in West Hollywood, California. He serves on the Scientific Boards of the Multiple Myeloma Research Foundation and the International Myeloma Foundation as well as working with many other groups known for their work in multiple myeloma and bone metastases.

After earning his Doctorate in Medicine from the University of California at San Diego, Dr. Berenson completed his internship and residency in internal medicine at the University of Utah Medical Center and fellowships in hematology/oncology at the University of California at Los Angeles (UCLA). He is certified by the American Board of Internal Medicine in both internal medicine and medical oncology. Currently in private practice, he has been affiliated most recently with Cedars-Sinai Medical Center as the Director of the Multiple Myeloma & Bone Metastasis Programs.